Novel Laboratories

Somerset, United States Founded: 2006 • Age: 20 yrs Acquired By Lupin Pharmaceuticals
ANDA dosage forms and delivery systems are developed and manufactured.

About Novel Laboratories

Novel Laboratories is a Healthcare company based in Somerset (United States) founded in 2006, and was acquired by Lupin Pharmaceuticals in July 2015. ANDA dosage forms and delivery systems are developed and manufactured. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.

Company details

Novel Laboratories was founded in 2006 in Somerset, United States. ANDA dosage forms and delivery systems are developed and manufactured by the company within the generic pharmaceuticals sector. Product approvals, including ANDAs, first-to-file submissions, and confirmed Paragraph IV certifications, have been obtained. Generic pharmaceuticals are sold through its affiliate, GAVIS Pharmaceuticals. The company and its affiliate were acquired by Lupin in July 2015.

Key Metrics

Investors in Novel Laboratories

Novel Laboratories has secured backing from 1 investor. Prominent investors backing the company include Lupin Pharmaceuticals.

All
InvestorDescriptionFounded YearDomainLocation
APIs, generics, and specialty pharma products are manufactured and marketed.
1968lupinpharmaceuticals.comBaltimore, United States
Premium access

Investor details for Novel Laboratories

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Novel Laboratories

2 dated milestones of Novel Laboratories across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded Novel Laboratories is founded.
  2. Exit Acquired by Lupin Pharmaceuticals.

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as Novel Laboratories (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of generics formulations
2002Bridgewater, New Jersey, United StatesUSD 3.02 B8,300
Biosimilar therapeutics are developed for oncology and autoimmune diseases.
2010Redwood City, California, United StatesUSD 143.62 MUSD 42.17 M228
Ophthalmic pharmaceuticals and instruments are developed for eye care.
1853Bridgewater, New Jersey, United StatesUSD 5.1 B13,500
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Novel Laboratories

Novel Laboratories was founded in 2006.

Novel Laboratories is headquartered in Somerset, United States.

Novel Laboratories was founded in 2006 in Somerset, United States. ANDA dosage forms and delivery systems are developed and manufactured by the company within the generic pharmaceuticals sector. Product approvals, including ANDAs, first-to-file submissions, and confirmed Paragraph IV certifications, have been obtained. Generic pharmaceuticals are sold through its affiliate, GAVIS Pharmaceuticals. The company and its affiliate were acquired by Lupin in July 2015.

Novel Laboratories has 1 investor. Key investors include Lupin Pharmaceuticals.

Yes. Novel Laboratories was acquired by Lupin Pharmaceuticals in July 2015.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available